ELIZABETH PELOQUIN: Open Payments
NPI 1992322655 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 12 payments from 7 companies in 2025. Trend: 2023 $122 · 2024 $73 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| PFIZER INC. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: LEQVIO, VYNDAQEL, CAMZYOS, JARDIANCE, FUROSCIX.
Industry payments across MA — which companies pay providers there.
